Effect of I-Shape Incısıon Technique on Inter-Implant Papilla: A Prospective Randomized Clinical Trial
NCT ID: NCT02996370
Last Updated: 2016-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2010-10-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group- ı shape incision
Second stage surgery was made I shape incision technique .
papilla fill index
The clinical photographs were taken baseline, 3 and 6 month. Two T shaped full-round hexagonal straight filaments, each 5 mm, were used in the taking of standardized images.
crestal bone loss
Crestal bone loss was measured on digital radiographs at baseline, 3 and 6 month with a Java program me (Image-J 3.0 NIH, Bethesda, USA)
probing depth
The change of probing depth between baseline, 3 and 6month. Probing depth was measured with a plastic periodontal probe (mm)
Modified sulcus bleeding index
Modified bleeding index was measured baseline, 3 and 6 month. Presence of bleeding on probing were performed at four sites of implants.
Modified plaque index
Modified plaque index was measured baseline, 3 and 6 month. Presence of plaque index was performed at four sites of implants.
Control group- midcrestal incision
In the control group second stage surgery was made using the conventional method, midcrestal technique.
papilla fill index
The clinical photographs were taken baseline, 3 and 6 month. Two T shaped full-round hexagonal straight filaments, each 5 mm, were used in the taking of standardized images.
crestal bone loss
Crestal bone loss was measured on digital radiographs at baseline, 3 and 6 month with a Java program me (Image-J 3.0 NIH, Bethesda, USA)
probing depth
The change of probing depth between baseline, 3 and 6month. Probing depth was measured with a plastic periodontal probe (mm)
Modified sulcus bleeding index
Modified bleeding index was measured baseline, 3 and 6 month. Presence of bleeding on probing were performed at four sites of implants.
Modified plaque index
Modified plaque index was measured baseline, 3 and 6 month. Presence of plaque index was performed at four sites of implants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
papilla fill index
The clinical photographs were taken baseline, 3 and 6 month. Two T shaped full-round hexagonal straight filaments, each 5 mm, were used in the taking of standardized images.
crestal bone loss
Crestal bone loss was measured on digital radiographs at baseline, 3 and 6 month with a Java program me (Image-J 3.0 NIH, Bethesda, USA)
probing depth
The change of probing depth between baseline, 3 and 6month. Probing depth was measured with a plastic periodontal probe (mm)
Modified sulcus bleeding index
Modified bleeding index was measured baseline, 3 and 6 month. Presence of bleeding on probing were performed at four sites of implants.
Modified plaque index
Modified plaque index was measured baseline, 3 and 6 month. Presence of plaque index was performed at four sites of implants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy soft tissue (bleeding on probing (BOP) ≤ 20%, Plaque Index ≤ 15%,
* in a need of at least two collateral implants in the maxilla from second premolar to second premolar
* sufficient keratinized tissue
* no bone augmentation procedures before implant placement
* use of tobacco 10N ≥ cigarettes daily
* sufficient distance between opposite occluding dentition at the proposed implant sites
Exclusion Criteria
* systemic diseases such as diabetes
* pregnant or lactating women
* radiation therapy in the head and neck area wihtin the previous 12 months,
* heavy smokers
* bruxism.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Özge PEHLİVANOĞLU
Özge PEHLİVANOĞLU, PhD,DDS Ege University, School of Dentistry
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EGE-OP 2013
Identifier Type: -
Identifier Source: org_study_id